Source: Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020



Rating:

Share or cite this content

Citations should be made in the following way:
Giuditta Benincasa, Dawn L. DeMeo, Kimberly Glass, Edwin K. Silverman, Claudio Napoli. Epigenetics and pulmonary diseases in the horizon of precision medicine: a review. Eur Respir J, 57 (6) 2003406; 10.1183/13993003.03406-2020

Member's Comments

No comment yet.

Related content which might interest you: The best papers in the ERJ: paediatric pulmonary diseases Source: Virtual Congress 2020 – The European Respiratory Journal editor's view: our best papers of last year Year: 2020 Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018 Year: 2019 Pathogenesis of ILDs, basic research year in review Source: ERS Courses: Interstitial Lung Diseases Year: 2019 Pathogenesis of ILDs, basic research year in review Source: ERS Course 2019 - Interstitial Lung Diseases Year: 2019 Precision medicine in airway diseases: moving to clinical practice Source: Eur Respir J, 50 (4) 1701655; 10.1183/13993003.01655-2017 Year: 2017 Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks? Source: Eur Respir J, 53 (3) 1900197; 10.1183/13993003.00197-2019 Year: 2019 Diagnosis of interstitial lung diseases and impact of guidelines: an issue only for pulmonologists? Source: Annual Congress 2007 - Controversies in the management of interstitial lung diseases Year: 2007 Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 COVID-19 and COPD: a narrative review of the basic science and clinical outcomes Source: Eur Respir Rev, 29 (158) 200199; 10.1183/16000617.0199-2020 Year: 2020 Reading list SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW11 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Reading list SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Source: International Congress 2016 – SW15 The new frontiers in exercise training in chronic obstructive pulmonary disease patients: technical aspects Year: 2016 Treatable traits: toward precision medicine of chronic airway diseases Source: Eur Respir J 2016; 47: 410-419 Year: 2016 Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020 Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era Source: Eur Respir Rev, 27 (148) 180004; 10.1183/16000617.0004-2018 Year: 2018